Brian Ferris
Vascular Surgery · Bellevue, WANPI 1104859081
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $118,323 of the $169,710 with a category attached, or 69.7%. Johnson & Johnson accounts for 65.6% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2019 at $90,033 and has fallen 99.9% since, to $109 in 2025. Among vascular surgery clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 254 payments — averaging $668.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$111K
- Boston Scientific$24K
- Biocompatibles, Inc.$23K
- Medtronic$10K
- Philips North America LLC$538
- Cook Medical LLC$296
- plus $858 from 14 others
Across 18 payments — averaging $2433.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bard Peripheral Vascular, Inc.$31K
- Abbott$12K
What the payments were for
- Consulting fees$19,87012%
- Speaking & faculty fees$118,32370%
- Travel & lodging$24,03214%
- Food & beverage$7,3774%
- Education$1080%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 128 | $111,364 |
| Boston Scientific | 53 | $23,679 |
| Biocompatibles, Inc. | 16 | $23,350 |
| Medtronic(2 entities) | 21 | $9,624 |
| Philips North America LLC | 5 | $538 |
| Cook Medical LLC | 10 | $296 |
| AbbVie | 2 | $257 |
| Silk Road Medical, Inc. | 2 | $141 |
| Access Vascular Inc | 1 | $109 |
| E.r. Squibb & Sons, L.L.C. | 4 | $72 |
| Bard Peripheral Vascular, Inc. | 3 | $66 |
| Inari Medical, Inc. | 1 | $59 |
| Abbott | 1 | $30 |
| Siemens Medical Solutions USA, Inc. | 1 | $26 |
| Organogenesis Inc. | 1 | $23 |
| Penumbra, Inc. | 1 | $17 |
| EKOS Corporation | 1 | $16 |
| Davol Inc. | 1 | $16 |
| Cardiva Medical, Inc. | 1 | $14 |
| W. L. Gore & Associates, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$109,916
- VARITHENA$23,244
- VenaSeal$9,030
- GENERAL - THERAPIES$5,496
- GENERAL VASCULAR INTERVENTION$4,470
- GENERAL ATHERECTOMY$525
- GENERAL NON VASCULAR INTERVENTION$450
- MVP$301
- GENERAL THROMBECTOMY$225
- IGT D Peripheral$155
- PHOENIX$147
- BOTOX$138
- ELUVIA$125
- ENROUTE Transcarotid Neuroprotection System$115
- ENROUTE Transcarotid Stent$115
- HYDROPICC$109
- HYDROMID$109
- HYDROPICC DUAL LUMEN$109
- VANNAS DEEP ACCESS VASCULAR SCISSORS$109
- Zilver PTX$109
How this compares
$169,710 in reported general payments places this provider in the 95th percentile of 111 vascular surgery providers in Washington.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 212 | $224,129 |
| EliquisApixaban | 45 | $52,817 |
| Atorvastatin Calcium | 40 | $551 |
| Rosuvastatin Calcium | 29 | $472 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $111,364 | $224,129212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 111 vascular surgery providers in Washington.
Other vascular surgery in Bellevue
- Kathleen GibsonBellevue$593K
- Mark OmbrellaroBellevue$12K
- Elica InagakiBellevue$10K
- Sooyeon KimBellevue$9K
- Renee MinjarezBellevue$6K
- Benjamin StarnesSeatle$666K
- Sara ZettervallSeattle$126K
- Paul HayesSeattle$83K
- Elina QuirogaSeattle$69K
- Lorena de Marco GarciaYakima$60K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.